The Korean Journal of Clinical Laboratory Science : eISSN 2288-1662 / pISSN 1738-3544

Table 2.

Clinical characteristics according to the UA/HDL-C ratio

Variable UA/HDL-C ratio (N=5,845) P-value
Quartile 1 (7.297)
(N=1,462)
Quartile 2 (7.298∼9.782)
(N=1,465)
Quartile 3 (9.783∼13.111)
(N=1,456)
Quartile 4 (13.112)
(N=1,462)
UA/HDL-C ratio 5.84±1.04 8.55±0.72 11.27±0.95 16.79±3.51 <0.001
Age (yr) 50.35±16.00 52.57±16.22 53.12±17.25 51.46±17.47 <0.001
Men 188 (12.9) 460 (31.4) 840 (57.7) 1,161 (79.7) <0.001
Hypertension 380 (26.1) 447 (30.5) 520 (35.8) 573 (39.3) <0.001
Obesity 259 (17.7) 418 (28.5) 533 (38.0) 780 (53.4) <0.001
T2DM 89 (6.1) 103 (7.0) 147 (10.1) 145 (9.9) <0.001
CKD 11 (0.8) 23 (1.6) 42 (2.9) 97 (6.6) <0.001
Albuminuria 102 (7.0) 114 (7.8) 137 (9.4) 184 (12.6) <0.001
uACR (mg/g) 17.32±74.13 19.35±96.89 24.88±128.93 38.07±187.50 <0.001

Non-albuminuria, uACR<30; Albuminuria, uACR≥30; Hypertension, SBP≥140 mmHg or DBP≥90 mmHg or medication; Obesity, BMI≥25 kg/m2; T2DM, FBG≥126 mg/dL or medication; CKD, eGFR≥60 mL/min/1.73 m2.

Mean±SD or n (%).

Abbreviation: UA, uric acid; HDL-C, high density lipoprotein cholesterol; T2DM, type 2 diabetes mellitus; uACR, urine microalbumin to urine creatinine ratio.

Korean J Clin Lab Sci 2023;55:167-73 https://doi.org/10.15324/kjcls.2023.55.3.167
© 2023 Korean J Clin Lab Sci